Pharmacokinetics of Norfloxacin in Carps
Xin Zhang
Abstract
Xin Zhang
Abstract
Pharmacokinetics of intramuscularly (i.m.) and orally administered at a dose of 10 mg/kg norfloxacin were investigated in carps. Serum norfloxacin concentration were measured using HPLC and concentration time data analyzed with 9 000 3P87 practical pharmacokinetics software. The results showed that the serum profiles of norfloxacin in carp were best described by a two compartment open model following i.m. and oral administration. After i.m. dosing, the parameters were: t 1/2α (0.127 9±0.013 0) h, t 1/2β (3.403 2±0.587 3) h, t 1/2ka (0.006 7±0.000 8) h, AUC ( 24.948 1 ±6.314 6) μg/(mL·h), CL S(0.400 8±0.103 5) mg/(kg·h), T peak (0.032 2±0.003 5) h, C max ( 16.899 2 ± 4.372 6 ) mg/L. After oral dosing, the parameters were: t 1/2α (3.407 1±1.069 8) h, t 1/2β (77.123 9± 21.387 5 ) h, t 1/2ka ( 0.149 1 ±0.013 0) h, AUC (150.602 9±35.427 8) μg/(mL ·h), CL S (0.066 4±0.002 1) mg/(kg·h), T peak (0.730 0± 0.010 2 ) h, C max (5.799 8±1.367 5) mg/L. This suggested that the main pharmacokinetic parameters of i.m. and oral administration were significantly different(P0.01).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Pharmacokinetics of intramuscularly (i.m.) and orally administered at a dose of 10 mg/kg norfloxacin were investigated in carps. Serum norfloxacin concentration were measured using HPLC and concentration time data analyzed with 9 000 3P87 practical pharmacokinetics software. The results showed that the serum profiles of norfloxacin in carp were best described by a two compartment open model following i.m. and oral administration. After i.m. dosing, the parameters were: t 1/2α (0.127 9±0.013 0) h, t 1/2β (3.403 2±0.587 3) h, t 1/2ka (0.006 7±0.000 8) h, AUC ( 24.948 1 ±6.314 6) μg/(mL·h), CL S(0.400 8±0.103 5) mg/(kg·h), T peak (0.032 2±0.003 5) h, C max ( 16.899 2 ± 4.372 6 ) mg/L. After oral dosing, the parameters were: t 1/2α (3.407 1±1.069 8) h, t 1/2β (77.123 9± 21.387 5 ) h, t 1/2ka ( 0.149 1 ±0.013 0) h, AUC (150.602 9±35.427 8) μg/(mL ·h), CL S (0.066 4±0.002 1) mg/(kg·h), T peak (0.730 0± 0.010 2 ) h, C max (5.799 8±1.367 5) mg/L. This suggested that the main pharmacokinetic parameters of i.m. and oral administration were significantly different(P0.01).
Key concepts: Norfloxacin, Pharmacokinetics, Dosing, Oral administration, High-performance liquid chromatography, Pharmacology, Biology, Chemistry